Exercise responses during endurance testing at different intensities in patients with COPD

Respiratory Medicine

Volumn 98, Issue 6, 2004, Pages 515-521

  Oga, Toru ^a   Nishimura, Koichi ^a   Tsukino, Mitsuhiro ^b   Sato, Susumu ^b  

^a KYOTO KATSURA HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Endurance exercise test; Endurance time; High intensity test; Moderate intensity test

Indexed keywords

BRONCHODILATING AGENT; CARBON DIOXIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; OXYGEN; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BICYCLE ERGOMETRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSPNEA; ENDURANCE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; LUNG FUNCTION TEST; MALE; OUTCOMES RESEARCH; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TIME; TOTAL LUNG CAPACITY; WORKLOAD;

EID: 2542537491     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.12.009     Document Type: Article

References (24)

1. Nici L. Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2000;21:693-704.
2. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: rote of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-9.
3. O'Donnell DE, Magnussen H, Aguilaniu B, Gerken F, Hamilton A, Flüge T Spiriva® (tiotropium) improves exercise tolerance in COPD. Am J Respir Crit Care Med 2002;165:A227.
4. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161:1897-901.
5. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-65.
6. O'Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD. Is spirometry useful? Chest 2000;117: 42S-7S.
7. Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152: S77-120.
8. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 2003;123:1810-6.
9. Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1994;152:1107-136.
10. Japan Society of Chest Diseases. The predicted values of pulmonary function testing in Japanese. Jpn J Thoracic Dis 1993;31: Appendix (in Japanese).
11. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exercise 1982;14:377-81.
12. Tobin MJ, Jenouri G, Danta I, Kim C, Watson H, Sackner MA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982;126: 670-5.
13. Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992;47: 70-5.
14. Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
15. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-32.
16. Cambach W, Chadwick-Straver RVM, Wagenaar RC, van Keimpema ARJ, Kemper HCG. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997;10:104-13.
17. Bye PTP, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis 1982;126:1005-12.
18. Matthews JI, Bush BA, Ewald FW. Exercise responses during incremental and high intensity and low intensity steady state exercise in patients with obstructive lung disease and normal control subjects. Chest 1989;96:11-7.
19. ERS Task Force on Standardization of Clinical Exercise Testing. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997;10:2662-89.
20. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983;55:1558-64.
21. Franco MJ, Olmstead EM, Tosteson ANA, Lentine T, Ward J, Mahler DA. Comparison of dyspnea ratings during submaximal constant work exercise with incremental testing. Med Sci Sports Exercise 1998;30:479-82.
22. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
23. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.
24. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Mishima M. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung 2002;31:374-81.